Literature DB >> 11684538

Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.

A Y McDermott1, A Shevitz, T Knox, R Roubenoff, J Kehayias, S Gorbach.   

Abstract

BACKGROUND: Alterations in body composition have been reported in HIV-positive adults receiving highly active antiretroviral therapy (HAART), but the magnitude and potential determinants of these changes are unclear.
OBJECTIVE: We compared total and regional body composition, as measured by dual-energy X-ray absorptiometry, in 203 HIV-positive men and 62 HIV-positive women according to HAART.
DESIGN: This was a cross-sectional analysis of a cohort study of nutrition and HIV infection.
RESULTS: After adjustment for age, weight, race, and exercise habits, total weight and fat mass did not differ significantly in men or women by HAART. Trunk fat was greater in men (1.0 kg; P < 0.001) and women (1.4 kg; P = 0.005) and leg fat was lower in men (-1.0 kg; P < 0.001) and women (-1.5 kg, P = 0.005) receiving HAART than in those not. This corresponded to a greater percentage of total fat mass located in the trunk (men: 7.5%, P < 0.001; women: 5.1%, P = 0.02). Lean mass was also greater with longer duration of HAART in men (P < 0.002). In men receiving HAART, total and regional bone mineral content were less than in the men not receiving HAART (P < 0.001). These effects increased with longer duration of HAART. Protease inhibitors were associated with the largest differences in regional fat.
CONCLUSIONS: HAART is associated with redistribution of fat mass from the legs to the trunk, despite no significant differences in total fat mass or weight. In men, HAART is also associated with a reduction in bone mineral content, suggesting that HAART increases the risk of central obesity and osteoporosis.

Entities:  

Mesh:

Year:  2001        PMID: 11684538     DOI: 10.1093/ajcn/74.5.679

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

Review 1.  Sex differences in antiretroviral therapy-associated intolerance and adverse events.

Authors:  Rebecca Clark
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.

Authors:  Kristine M Erlandson; Douglas Kitch; Camlin Tierney; Paul E Sax; Eric S Daar; Pablo Tebas; Kathleen Melbourne; Belinda Ha; Nasreen C Jahed; Grace A McComsey
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

3.  Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors:  Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

4.  Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

Authors:  C J Chantry; J S Cervia; M D Hughes; C Alvero; J Hodge; P Borum; J Moye
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

Review 5.  Geriatric syndromes: new frontiers in HIV and sarcopenia.

Authors:  Kellie L Hawkins; Todd T Brown; Joseph B Margolick; Kristine M Erlandson
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

6.  Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Authors:  Sara E Dolan; Jenna R Kanter; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

Review 7.  Seizures in HIV-seropositive individuals: epidemiology and treatment.

Authors:  Frank Romanelli; Melody Ryan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Predictors of body composition changes during tuberculosis treatment in Mwanza, Tanzania.

Authors:  G PrayGod; N Range; D Faurholt-Jepsen; K Jeremiah; M Faurholt-Jepsen; M G Aabye; P Magnussen; J Changalucha; A B Andersen; J C K Wells; H Friis
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

9.  Psychiatric and neurophysiological predictors of obesity in HIV/AIDS.

Authors:  Lance O Bauer
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

10.  Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?

Authors:  M I Spagnuolo; E Bruzzese; G F Vallone; N Fasano; G De Marco; A Officioso; G Valerio; M Volpicelli; R Iorio; A Franzese; A Guarino
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.